Article originally published by SpinalNews SynerFuse has announced that Michael Park (University of Minnesota, Minneapolis, USA)—principal investigator for the company’s investigational device exemption (IDE) proof-of-concept study—presented…
Dr Timothy SteelMay 2, 2023